Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S B
(OP:
NONOF
)
136.12
+1.96 (+1.46%)
Streaming Delayed Price
Updated: 11:17 AM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S B
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
May 14, 2024
The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug.
Via
Benzinga
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.
Via
InvestorPlace
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
November 23, 2023
This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure.
Via
Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
October 09, 2023
Via
Benzinga
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
September 11, 2023
Via
Benzinga
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
July 03, 2023
Via
Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
August 17, 2022
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors.
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.